Name: Gastroenteropancreatic System and Its Tumors: Part II, an Issue of Endocrinology and Metabolism Clinics: Volume 40-1 (en Inglés)
Price: 75600.00 CLP
Availability: InStock
Author: Vinik, Aaron I.
ISBN: 9781455704408

portada Gastroenteropancreatic System and Its Tumors: Part II, an Issue of Endocrinology and Metabolism Clinics: Volume 40-1 (en Inglés)

Formato

Libro Físico

Autor

Aaron I. Vinik

Editorial

Saunders

Año

2011

Idioma

Inglés

N° páginas

288

Encuadernación

Tapa Dura

Peso

1.18

ISBN13

9781455704408

Categorías

El metabolismo
Oncología
Endocrinología

Gastroenteropancreatic System and Its Tumors: Part II, an Issue of Endocrinology and Metabolism Clinics: Volume 40-1 (en Inglés)

Aaron I. Vinik (Autor) · Saunders · Tapa Dura

Libro Físico

$ 75.600

$ 151.190

Ahorras: $ 75.590

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 06 de Junio y el Martes 18 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Gastroenteropancreatic System and Its Tumors: Part II, an Issue of Endocrinology and Metabolism Clinics: Volume 40-1 (en Inglés)"

This two-part issue of Endocrinology and Metabolism Clinics of North America provides the endocrinologist with comprehensive essential updates about tumors of the gastroenteropancreatic system. Topics covered include the history and development of the gastroenteropancreatic endocrine axis; the changing face and epidemiology of neuroendocrine tumors (NETs); chromogranins current state of the art, pathology of gastroenteropancreatic (GEP) disorders; new and emerging syndromes related to gastrointestinal (GI) hormones; an update on incretins; prospects for ghrelin in the clinic, obesity/appetite and hedonism; GI motility disorders; gastric bypass and GI hormones; pancreatic exocrine function and GI hormones; harnessing the pancreatic stem cell; how to diagnose NETs before there are METs; NETs in kids: combining the SEER data for children and adults with site differences; novel biomarkers for NETs; standard imaging techniques for NETs; novel peptide imaging: glucagon receptor; signaling mechanism in NETs as targets for therapy; update on clinical trials; nutrition and the GEP; peptide radiotherapy; in vitro analysis of NETs: the role of angiogenesis; modern lab evaluation of peptide and amines: a continuing role for radioimmunoassay?; surgery/surgical management of NETs; and evaluation and quality of life in NETs patients.